Indian Drugmaker Fined $50 Mn By US Govt For Irregularities

The US’ Department of Justice has fined an Indian drugmaker with $50 million for supplying low-grade active pharmaceutical ingredients used in cancer drugs distributed in the US. Reportedly, the Fresenius Kabi Oncology Limited (FKOL) had violated the Food and Drug Administration’s guidelines, concealed and spoiled records with FDA investigators. Moreover, the FDA said Active Pharmaceutical Ingredients produced at FKOL’s Bengal-based plant "put vulnerable patients at risk”.